Monday, June 1, 2015

ASCO: Survival Benefit With Docetaxel in High-Risk Prostate Cancer

(MedPage Today) -- For the first time, adjuvant chemotherapy improves survival in the localized setting
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)